Table 5.
Gene-specific rates of tumor detection using imaging screening for the total cohort.
Subjects with true positive screens (excluding recurrence) (n) | Total subjects (n) | Percent positive subjects | |
---|---|---|---|
SDHA | 1 | 9 | 11% |
SDHB | 29 | 188 | 15% |
SDHC | 1 | 28 | 4% |
SDHD | 14 | 35 | 40% |
SDHAF2 | 0 | 3 | 0.00% |
Total | 45 | 263 | 17% |
True positive means tumor was SDHx-related including PGL/PCC, RCC or GIST